Schedule 13G ownership disclosure

ArriVent Biopharma Inc

Common Stock, par value $0.0001 per share · CUSIP: 04272N102

Event date: 2025-12-31

Filing-level shares
3,929,117.00
Percent of class
9.5%
  • Hillhouse Investment Management, Ltd.

    Shares: 3,929,117.00 · Class: 9.5%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000902664-26-001013
Form type
SCHEDULE 13G/A
Filer
ArriVent BioPharma, Inc.
CIK
CIK 1868279
Filed
Feb 17, 2026
Reporting period
Dec 31, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub